Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
about
Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic ratsCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseEndothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome.Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.Sensitivity to endothelin-1 is decreased in isolated livers of endothelial constitutive nitric oxide synthase knockout mice.Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver.Role of endothelin in fibrosis and anti-fibrotic potential of bosentan.Role of endothelin in systemic and portal resistance in cirrhosis.Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C.Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model.A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionEffects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration.Distinct patterns of gene expression in hepatocellular carcinomas and adjacent non-cancerous, cirrhotic liver tissues in rats fed a choline-deficient, L-amino acid-defined diet.Biology of portal hypertension.A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cells.Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.
P2860
Q24685743-2F22D89A-C277-4B5F-B429-7FE3250C5C34Q30473375-188FE3CF-76F7-47FB-8994-209B45C528E2Q30488861-E4CD0806-A474-44DC-BE11-075DF36837DDQ33671280-7993CAFA-0845-4B54-9EBD-57114276C66CQ34559070-9EDFFA8D-DD4F-4ED8-B4AD-DA44EB71849BQ35220034-C406BC8B-915E-404F-8B8C-B8D2DF239A4EQ35746861-FBE3BBE7-652C-4DE2-A5AF-876DF4E388A4Q36132271-6DBCC53F-8445-4D10-9993-D45050C6F82EQ36564609-3774C35C-EC83-4911-B51E-B218242FFA43Q40211269-572F5B81-C356-44D0-91C1-E6F2F72B906DQ41484298-8F71F11C-8F33-4131-A1F9-56C61D817A64Q41642597-9A668A20-5F3B-4E02-991F-3BABD1E741CCQ43248646-B7265A3C-C029-42AD-97DD-5F7E15477667Q46625990-D119F540-4AE7-44C0-9C1C-E7E11439094AQ47874043-0C28489E-7FAD-41B6-8100-84AD27169229Q52733599-FDE88CF2-1514-4066-B9B6-F919A869BA7CQ54383684-99A52DD4-3A5C-4689-9CDA-5006A1522E79
P2860
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
@en
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
@nl
type
label
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
@en
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
@nl
prefLabel
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
@en
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
@nl
P2093
P2860
P1433
P1476
Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.
@en
P2093
Kamegaya Y
Nakamura M
Yokomori H
P2860
P304
P356
10.1034/J.1600-0676.2001.021002114.X
P577
2001-04-01T00:00:00Z